Generic penetration in the retail atypical antipsychotic market

Susan Lenderts, Amir H. Kalali, Peter F Buckley

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In this article, we explore the penetration of generic atypical antipsychotics in the United States market before and after the availability of generic risperidone in July 2008. Analysis suggests that, overall, generic penetration into the atypical antipsychotic market has grown from approximately three percent in January 2008 to more than 25 percent in December 2009. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.

Original languageEnglish (US)
Pages (from-to)9-10
Number of pages2
JournalPsychiatry (Edgemont)
Volume7
Issue number3
StatePublished - Mar 1 2010

Fingerprint

Antipsychotic Agents
Risperidone
Prescriptions

Keywords

  • Atypical antipsychotic
  • Brand
  • Generic
  • Generic penetration
  • Prescription
  • Psychiatrists
  • Risperidone
  • Trade

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Lenderts, S., Kalali, A. H., & Buckley, P. F. (2010). Generic penetration in the retail atypical antipsychotic market. Psychiatry (Edgemont), 7(3), 9-10.

Generic penetration in the retail atypical antipsychotic market. / Lenderts, Susan; Kalali, Amir H.; Buckley, Peter F.

In: Psychiatry (Edgemont), Vol. 7, No. 3, 01.03.2010, p. 9-10.

Research output: Contribution to journalArticle

Lenderts, S, Kalali, AH & Buckley, PF 2010, 'Generic penetration in the retail atypical antipsychotic market', Psychiatry (Edgemont), vol. 7, no. 3, pp. 9-10.
Lenderts S, Kalali AH, Buckley PF. Generic penetration in the retail atypical antipsychotic market. Psychiatry (Edgemont). 2010 Mar 1;7(3):9-10.
Lenderts, Susan ; Kalali, Amir H. ; Buckley, Peter F. / Generic penetration in the retail atypical antipsychotic market. In: Psychiatry (Edgemont). 2010 ; Vol. 7, No. 3. pp. 9-10.
@article{4e00c89f83b24115b3fd2f8070bdce90,
title = "Generic penetration in the retail atypical antipsychotic market",
abstract = "In this article, we explore the penetration of generic atypical antipsychotics in the United States market before and after the availability of generic risperidone in July 2008. Analysis suggests that, overall, generic penetration into the atypical antipsychotic market has grown from approximately three percent in January 2008 to more than 25 percent in December 2009. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.",
keywords = "Atypical antipsychotic, Brand, Generic, Generic penetration, Prescription, Psychiatrists, Risperidone, Trade",
author = "Susan Lenderts and Kalali, {Amir H.} and Buckley, {Peter F}",
year = "2010",
month = "3",
day = "1",
language = "English (US)",
volume = "7",
pages = "9--10",
journal = "Psychiatry",
issn = "2158-8333",
publisher = "Matrix Medical Communications",
number = "3",

}

TY - JOUR

T1 - Generic penetration in the retail atypical antipsychotic market

AU - Lenderts, Susan

AU - Kalali, Amir H.

AU - Buckley, Peter F

PY - 2010/3/1

Y1 - 2010/3/1

N2 - In this article, we explore the penetration of generic atypical antipsychotics in the United States market before and after the availability of generic risperidone in July 2008. Analysis suggests that, overall, generic penetration into the atypical antipsychotic market has grown from approximately three percent in January 2008 to more than 25 percent in December 2009. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.

AB - In this article, we explore the penetration of generic atypical antipsychotics in the United States market before and after the availability of generic risperidone in July 2008. Analysis suggests that, overall, generic penetration into the atypical antipsychotic market has grown from approximately three percent in January 2008 to more than 25 percent in December 2009. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.

KW - Atypical antipsychotic

KW - Brand

KW - Generic

KW - Generic penetration

KW - Prescription

KW - Psychiatrists

KW - Risperidone

KW - Trade

UR - http://www.scopus.com/inward/record.url?scp=77956077489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956077489&partnerID=8YFLogxK

M3 - Article

C2 - 20436769

AN - SCOPUS:77956077489

VL - 7

SP - 9

EP - 10

JO - Psychiatry

JF - Psychiatry

SN - 2158-8333

IS - 3

ER -